# Randy D. Gascoyne

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/randy-d-gascoyne/

## Facts

| Field | Value |
| --- | --- |
| Citations | 108,387 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 153 |
| i10-index | 498 |
| OpenAlex ID | https://openalex.org/A5031758990 |
| ORCID iD | https://orcid.org/0000-0002-2610-5690 |
| Works | 1,004 |

## Researcher papers

- [Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin](https://scholariq.org/papers/somatic-mutations-altering-ezh2-tyr641-in-follicular-and-diffuse-large-b-cell/)
- [Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma](https://scholariq.org/papers/rituximab-chop-versus-chop-alone-or-with-maintenance-rituximab-in-older-patients/)
- [Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma](https://scholariq.org/papers/tumor-associated-macrophages-and-survival-in-classic-hodgkin-s-lymphoma/)
- [An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era](https://scholariq.org/papers/an-enhanced-international-prognostic-index-nccn-ipi-for-patients-with-diffuse/)
- [MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program](https://scholariq.org/papers/myc-bcl2-protein-coexpression-contributes-to-the-inferior-survival-of-activated/)
- [MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers](https://scholariq.org/papers/mhc-class-ii-transactivator-ciita-is-a-recurrent-gene-fusion-partner-in-lymphoid/)
- [BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma](https://scholariq.org/papers/bcl2-translocation-defines-a-unique-tumor-subset-within-the-germinal-center-b/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.